Search

Search Constraints

You searched for: Author/Creator Bouma, Gerd

Search Results

13. Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease. Issue 11 (8th November 2017)

14. Cytotoxic T Lymphocyte Antigen–4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis. (31st March 2013)

15. Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1. Issue 6 (24th June 2021)

16. Differential IL-13 Production by Small Intestinal Leukocytes in Active Coeliac Disease versus Refractory Coeliac Disease. (15th April 2013)

17. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. (October 2014)

18. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. (October 2014)

19. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

20. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022)